European Commission Communication on Orphan Products

The aim of Regulation (EC) No 141/2000 (1) on orphan medicinal products is to stimulate medicinal product research in the area of rare diseases by outlining the Union procedure for the designation of orphan medicinal products and provides incen­tives for research and development on such products and placing them on the market.

However, questions still remained regarding the EU’s Orphan Regulation and so in November 2015, the European Commission released a public consultation on the subject. Following the results of this consultation the European Commission (EC) has since released a new communication which is intended to address some of these queries.

To read more about this, please click here.

To read the European Commission’s communication, please click here.

 

Tagged with

Published 6. January 2017 in News EU